Interventional Care
ICT: Focus on Surface Disinfection When Fighting COVID-19
Infection Control Today recently published an article written by William A. Rutala, PhD, MPH, CIC and David J. Weber, MD, MPH
Focus on Surface Disinfection When Fighting COVID-19
Source: ICT
Excerpt from article:
“Based on the EPA emerging viral pathogen criteria, an EPA-registered, hospital disinfectant must have a disinfectant efficacy claim against at least 1 small or 1 large non-enveloped virus to be eligible for use against an enveloped emerging viral pathogen.2 EPA’s List N identifies which registered products have this designation on their Master Label.³
Why does this matter? Over the past decade, there has been a growing appreciation that environmental contamination of hospital surfaces promotes infection transmission for many pathogens. Studies with epidemiologically important pathogens (e.g., MRSA, VRE, C. difficile) have shown that surfaces are contaminated and the frequency of hand contamination correlates to the frequency of environmental contamination.”